Rhoon, the Netherlands - A new analysis of the COMET study shows that carvedilol reduces vascular events to a greater extent than metoprolol, an effect that the authors suggest likely contributes to ...

BOSTON -- Carvedilol (Coreg, Coreg CR) helped to mitigate cardiac risk in patients undergoing pheochromocytoma surgery, researchers reported here. In a comparison of several blood pressure (BP) ...

Strasbourg, France - Further details of the results of the Carvedilol or Metoprolol European Trial (COMET), comparing the beta blockers carvedilol and metoprolol in heart failure, were presented at ...

Findings from PREVENT-HF put to rest the idea that once remodeling in the heart's structure starts following anthracyclines that nothing can be done to treat it. Giving childhood cancer survivors the ...

Patients with cirrhosis are at risk for developing portal hypertension that can lead to the formation, dilation, and rupture of esophageal varices. The annual incidence of esophageal varices is ...

Results showed that compared to metoprolol, those who initiated carvedilol had a greater all-cause (HR, 1.08; 95% CI,1.02-1.16) and cardiovascular mortality (HR, 1.18; 95% CI, 1.08-1.29). Among ...

Physicians at City of Hope, one of the largest cancer research and treatment organizations in the United States, in cooperation with the Children's Oncology Group (COG), have conducted the largest ...